Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 10,70€(+160,98%). Der Median liegt bei 10,70€(+160,98%).
Kaufen | 0 |
Halten | 8 |
Verkaufen | 1 |
Scoring-Modelle
Dividenden-Strategie | 0 / 15 |
HGI-Strategie | 4 / 18 |
Levermann-Strategie | -6 / 13 |
News
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 3, 2025, Fortrea rele.» Mehr auf businesswire.com
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FORTREA HOLDINGS INC. (FTRE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights.» Mehr auf businesswire.com
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 3, 2025, Fortrea released its fourth quarter and fu.» Mehr auf businesswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 602,03 Mio | 1,87% |
Bruttoeinkommen | 0,00 | 100,00% |
Nettoeinkommen | −520,32 Mio | 455,99% |
EBITDA | −509,13 Mio | 2.717,86% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 369,44 Mio€ |
Anzahl Aktien | 90,54 Mio |
52 Wochen-Hoch/Tief | 26,15€ - 4,00€ |
Dividenden | Nein |
Beta | 2,13 |
KGV (PE Ratio) | −0,53 |
KGWV (PEG Ratio) | 0,00 |
KBV (PB Ratio) | 0,48 |
KUV (PS Ratio) | 0,15 |
Unternehmensprofil
Fortrea Holdings Inc. bietet Lösungen für die klinische Entwicklung und den Zugang zu Patienten in der Biowissenschaftsbranche. Das Unternehmen bietet Management von klinischen Studien der Phasen I-IV, klinische Pharmakologie, differenzierte technologiegestützte Studienlösungen und Dienstleistungen nach der Zulassung. Das Unternehmen beliefert Pharma-, Biotechnologie- und Medizintechnikunternehmen. Fortrea Holdings Inc. hat seinen Sitz in Durham, North Carolina.
Name | FORTREA HOLDINGS DL-,001 Aktie |
CEO | Thomas H. Pike |
Sitz | Durham, nc USA |
Website | |
Industrie | Gesundheitswesen: Ausstattung und Produkte |
Börsengang | |
Mitarbeiter | 15.000 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | FTRE |
Frankfurt | K67.F |
Düsseldorf | K67.DU |
München | K67.MU |
Assets entdecken
Shareholder von FORTREA HOLDINGS DL-,001 Aktie investieren auch in folgende Assets